Skip to main content
Premium Trial:

Request an Annual Quote

Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for an at-home sample collection kit for SARS-CoV-2 molecular testing developed by nonprofit digital health firm Audere.

The [email protected] kit is designed for the self-collection of anterior nasal swab specimens by individuals aged 16 and older, as well as the collection of samples by adults in individuals aged 2 and older. Samples can be transported at ambient temperatures for in vitro diagnostic SARS-CoV-2 RNA testing.

Testing of [email protected] samples is limited to Audere-designated labs that are CLIA-certified to perform high-complexity tests, according to the FDA.

In addition to the sample collection kit, Seattle-based Audere has developed a COVID-19 symptom tracking and surveillance tool that is currently used by a local fire department.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.